Current Edition

Biopharma

Love Pharma moves to buy transdermal opioid-use disorder player

Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property covering …

Continue Reading →
biopharmaceutical

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by …

Continue Reading →
COVID-19 vaccine

Hyper-collaboration in Healthcare and Life Sciences – The New Paradigm

The COVID-19 pandemic demonstrated the ability of the healthcare and life science industry to respond to unexpected needs with unprecedented speed. However, independent of the …

Continue Reading →
COVID-19

The Brave New World of Rapid Drug Development

The COVID-19 pandemic has brought the topic of rapid drug development to the forefront of the life sciences sector. Ray Chohan at PatSnap, believes that …

Continue Reading →
AiPharma

AiPharma forms alliance with Appili Therapeutics

Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Therapeutics Inc (Appili), to advance the global development …

Continue Reading →
biological

Biotech in China: Maximising the Global Opportunity

Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological field. According to Sy …

Continue Reading →
clinical trials

The Case for a Distributable CDx Model

The past decade has been an exciting era in healthcare for patients and providers with the increasingly broad adoption of precision medicine in drug development, …

Continue Reading →
Aetion

Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership brings …

Continue Reading →
bespoke

Almac Group Launches Bespoke Elemental Impurities Laboratory

The pharmaceutical industry is currently facing stringent new demands on elemental impurities from regulators stipulating the control and documentation of elemental impurities in drug products, …

Continue Reading →
API

Saneca Pharma strengthens team with new sales director

Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has strengthened its team with the appointment of a new CDMO sales director as it continues …

Continue Reading →